Simple Summary Head and neck photoimmunotherapy (HN-PIT) is a new treatment
developed for local control of head and neck carcinoma. This study assessed the quality of …

Simple Summary Photoimmunotherapy is a novel cancer treatment that recently became
covered by national health insurance only in Japan. We investigated the characteristics of …

Simple Summary RM-1929 near-infrared photoimmunotherapy (NIR-PIT) is an emerging
treatment that is currently being investigated under a world-wide Phase III clinical trial and …

6014 Background: Patients with rHNSCC who have failed standard of care have poor
prognoses and limited therapeutic options. In this study, final results are reported of a phase …

TPS6094 Background: rHNSCC commonly affects local or regional sites and is associated
with considerable morbidity and mortality. Outcomes of these patients remain poor with …

Simple Summary Near-infrared photoimmunotherapy (NIR-PIT) represents a potential novel
treatment modality for a range of cancer types, including head and neck cancers. NIR-PIT is …

Photoimmunotherapy (PIT) targets and destroys tumor cells through irradiation with 690-nm
red light after the administration of cetuximab sarotalocan sodium, which contains …

Background Recurrent head and neck squamous cell carcinoma (rHNSCC) represents a
significant global health burden with an unmet medical need. In this study we determined …

6039 Background: Patients with recurrent HNSCC (rHNSCC) have limited therapeutic
options and poor prognosis. We report promising results of a Phase 2a trial of …

Photoimmunotherapy for head and neck cancer (HNC-PIT) is a newly developed
locoregional treatment targeting the epidermal growth factor. This treatment consists in …